A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
< b > Condition < /b > : Irritable Bowel Syndrome Characterized by Constipation < br/ > < b > Interventions < /b > : Drug: Linaclotide; Drug: Placebo < br/ > < b > Sponsors < /b > : Ironwood Pharmaceuticals, Inc.; University Hospital of South Manchester NHS Foundation Trust < br/ > < b > Not yet recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Constipation | Foundation Trusts | Hospitals | Irritable Bowel Syndrome | Research | Study